Literature DB >> 11463575

Regulation of apoA1 gene expression with acidosis: requirement for a transcriptional repressor.

M J Haas1, D Reinacher, J P Li, N C Wong, A D Mooradian.   

Abstract

Serum apolipoprotein A(1) (apoA(1)) concentration is inversely correlated with the risk of premature atherosclerosis. Serum apoA(1) concentrations are regulated, in part, at the transcriptional level. ApoA(1) mRNA is synthesized primarily in the liver and small intestine, under the direction of a number of signaling molecules and tissue-specific regulatory elements. Previously, we demonstrated that extracellular acidosis suppresses apoA(1) mRNA levels at the level of transcription. Here we demonstrate that intracellular acidosis, in the absence of extracellular pH changes, represses apoA(1) promoter activity. Repression occurs through a pH responsive element (pH-RE) located within the apoA(1) gene promoter. Acidosis increases the specific DNA binding activity of a putative repressor protein within the immediate 5'-flanking region of the apoA(1) gene. The cis-element that binds the putative repressor protein contains a negative thyroid hormone response element (nTRE) located 3' and adjacent to the apoA(1) TATA box. Mutation of the nTRE/pH-RE abrogates protein binding and alters the activity of reporter genes controlled by this element. Repression by acidosis did not require de novo mRNA and protein synthesis. Inhibition of tyrosine kinase activity and diacylglycerol-stimulated protein kinase C (PKC) signaling pathways with tyrophostin A47 and phorbol myristate acetate, respectively, did not affect the repression of apoA(1) promoter activity with acidosis. These results suggest that transcriptional repression of the apoA(1) gene by alterations in ambient pH is associated with enhanced DNA binding activity of a repressor protein, through a mechanism which appears to be independent of de novo mRNA and protein synthesis, tyrosine kinase activity, or PKC activation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11463575     DOI: 10.1677/jme.0.0270043

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  7 in total

Review 1.  The emerging role of HDL in glucose metabolism.

Authors:  Brian G Drew; Kerry-Anne Rye; Stephen J Duffy; Philip Barter; Bronwyn A Kingwell
Journal:  Nat Rev Endocrinol       Date:  2012-01-24       Impact factor: 43.330

2.  Effect of experimentally induced metabolic acidosis on aortic endothelial permeability and serum nitric oxide concentration in normal and high-cholesterol fed rabbits.

Authors:  Majid Khazaei; Mehdi Nematbakhsh
Journal:  Arch Med Sci       Date:  2012-09-08       Impact factor: 3.318

3.  Carbonic Anhydrase Inhibition Ameliorates Inflammation and Experimental Pulmonary Hypertension.

Authors:  Hannes Hudalla; Zoe Michael; Nicolas Christodoulou; Gareth R Willis; Angeles Fernandez-Gonzalez; Evgenia J Filatava; Paul Dieffenbach; Laura E Fredenburgh; Robert S Stearman; Mark W Geraci; Stella Kourembanas; Helen Christou
Journal:  Am J Respir Cell Mol Biol       Date:  2019-10       Impact factor: 7.748

4.  The effects of short-chain fatty acids on the transcription and secretion of apolipoprotein A-I in human hepatocytes in vitro.

Authors:  Jehad Z Tayyeb; Herman E Popeijus; Ronald P Mensink; Maurice C J M Konings; Kim H R Mulders; Jogchum Plat
Journal:  J Cell Biochem       Date:  2019-05-20       Impact factor: 4.429

5.  The Mechanism of Bisphenol A Atherogenicity Involves Apolipoprotein A-I Downregulation through NF-κB Activation.

Authors:  Violeta G Trusca; Madalina Dumitrescu; Ioana M Fenyo; Irina F Tudorache; Maya Simionescu; Anca V Gafencu
Journal:  Int J Mol Sci       Date:  2019-12-12       Impact factor: 5.923

6.  Short-Chain Fatty Acids (Except Hexanoic Acid) Lower NF-kB Transactivation, Which Rescues Inflammation-Induced Decreased Apolipoprotein A-I Transcription in HepG2 Cells.

Authors:  Jehad Z Tayyeb; Herman E Popeijus; Ronald P Mensink; Maurice C J M Konings; Fatma B A Mokhtar; Jogchum Plat
Journal:  Int J Mol Sci       Date:  2020-07-18       Impact factor: 5.923

7.  KIT is required for hepatic function during mouse post-natal development.

Authors:  Laetitia Magnol; Marie-Clémence Chevallier; Valérie Nalesso; Stéphanie Retif; Helmut Fuchs; Martina Klempt; Patricia Pereira; Michel Riottot; Sandra Andrzejewski; Bich-Thuy Doan; Jean-Jacques Panthier; Anne Puech; Jean-Claude Beloeil; Martin Hrabe de Angelis; Yann Hérault
Journal:  BMC Dev Biol       Date:  2007-07-05       Impact factor: 1.978

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.